원격 환자 모니터링 시스템 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Remote Patient Monitoring System Market Summary

The global remote patient monitoring system market size was valued at USD 26.0 billion in 2025 and is projected to grow from USD 30.9 billion in 2026 to USD 110.7 billion by 2033, at a CAGR of 20.0% from 2026 to 2033. North America dominated the market and accounted for a 40.4% share in 2025. The global market growth is driven by the increasing prevalence of chronic diseases, rising adoption of telehealth and digital health platforms, technological advancements in wearable and connected devices, and growing preference for home healthcare and remote care services.

Global Remote Patient Monitoring System Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global remote patient monitoring systems market report based on product, application, end use and region:

• Product Outlook (Revenue, USD Billion, 2021 - 2033)
• Vital Sign Monitors
  • Blood Pressure Monitors
  • Pulse Oximeters
  • Heart Rate Monitor (ECG)
  • Temperature Monitor
  • Respiratory Rate Monitor
  • Capnographs
  • Spirometers
  • Brain Monitoring (EEG)
• Special Monitors
  • Anesthesia Monitors
  • Blood Glucose Monitors
  • Cardiac Rhythm Monitor
  • Respiratory Monitor
  • Fetal Heart Monitors
  • Prothrombin Monitors
  • Multi Parameter Monitors (MPM)
  • Others
• Application Outlook (Revenue, USD Billion, 2021 - 2033)
• Cancer
• Cardiovascular Diseases
• Diabetes
• Sleep Disorder
• Weight Management and Fitness Monitoring
• Bronchitis
• Infections
  • Eye infections
  • Sinus Infections
  • Strep Throat
• Virus
• Dehydration
• Hypertension
• End Use Outlook (Revenue, USD Billion, 2021 - 2033)
• Hospital-Based Patients
• Ambulatory Patients
• Home Healthcare
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.1.2. Approach 1: Volume price analysis
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Remote Patient Monitoring Systems Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Pricing Model Analysis
  • 3.2.1. Subscription-Based Pricing (Annual or Monthly)
  • 3.2.2. Usage-Based or Pay-Per-Interaction
  • 3.2.3. Volume-Based Discount Model
  • 3.2.4. Bundled Pricing Model
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
    • 3.3.1.1. Increasing Prevalence of Chronic Diseases
    • 3.3.1.2. Rising adoption of telehealth and digital health platforms
    • 3.3.1.3. Technological advancements in wearable and connected devices
  • 3.3.2. Market restraint analysis
    • 3.3.2.1. Limited reimbursement policies and regulatory variability across regions
  • 3.3.3. Market opportunity analysis
  • 3.3.4. Market challenge analysis
• 3.4. Surgical Instrument Tracking Systems: Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTLE Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic landscape
    • 3.4.2.3. Social landscape
    • 3.4.2.4. Technological landscape
    • 3.4.2.5. Environmental landscape
    • 3.4.2.6. Legal landscape

Chapter 4. Remote Patient Monitoring Systems Market Segment Analysis, By Product Type, 2021 - 2033 (USD Billion)

• 4.1. Definition and Scope
• 4.2. Product Market Share Analysis, 2025 & 2033
• 4.3. Segment Dashboard
• 4.4. Global Remote Patient Monitoring Systems Market, by Product, 2021 to 2033
  • 4.4.1. Vital Sign Monitors
    • 4.4.1.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.4.1.2. Blood Pressure Monitors
      • 4.4.1.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.4.1.3. Pulse Oximeters
      • 4.4.1.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.4.1.4. Heart Rate Monitor
      • 4.4.1.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.4.1.5. Temperature Monitors
      • 4.4.1.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.4.1.6. Respiratory Rate Monitors
      • 4.4.1.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
        • 4.4.1.6.1.1. Canographs
          • 4.4.1.6.1.1.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
        • 4.4.1.6.1.2. Spirometers
          • 4.4.1.6.1.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.4.1.7. Brain Monitoring (EEG)
      • 4.4.1.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 4.5. Special Monitors
  • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.5.1.1. Anesthesia Monitor
      • 4.5.1.1.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.5.1.2. Blood Glucose Monitor
      • 4.5.1.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.5.1.3. Cardiac Rhythm Monitor
      • 4.5.1.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.5.1.4. Respiratory Monitor
      • 4.5.1.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.5.1.5. Fetal Heart Monitor
      • 4.5.1.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.5.1.6. Prothrombin Monitor
      • 4.5.1.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.5.1.7. Multi Parameter Monitor
      • 4.5.1.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.5.1.8. Others Monitor
      • 4.5.1.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 5. Remote Patient Monitoring Systems Market Segment Analysis, By Application, 2021 - 2033 (USD Billion)

• 5.1. Definition and Scope
• 5.2. Application Market Share Analysis, 2025 & 2033
• 5.3. Segment Dashboard
• 5.4. Global Remote Patient Monitoring Systems Market, by Application, 2021 to 2033
• 5.5. Cancer
  • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.6. Cardiovascular Diseases
  • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.7. Diabetes
  • 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.8. Sleep Disorder
  • 5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.9. Weight Management and Fitness Monitoring
  • 5.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.10. Bronchitis
  • 5.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.11. Infections
  • 5.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 5.11.1.1. Eye infections
      • 5.11.1.1.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 5.11.1.2. Sinus Infections
      • 5.11.1.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 5.11.1.3. Strep Throat
      • 5.11.1.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.12. Virus
  • 5.12.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.13. Dehydration
  • 5.13.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.14. Hypertension
  • 5.14.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 6. Remote Patient Monitoring Systems Market Segment Analysis, By End Use, 2021 - 2033 (USD Billion)

• 6.1. Definition and Scope
• 6.2. End use Market Share Analysis, 2025 & 2033
• 6.3. Segment Dashboard
• 6.4. Global Remote Patient Monitoring Systems Market, by End Use, 2021 to 2033
• 6.5. Hospital-based patients
  • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 6.6. Ambulatory patients
  • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 6.7. Home Healthcare
  • 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 7. Remote Patient Monitoring Systems Market Segment Analysis, By Region, 2021 - 2033 (USD Billion)

• 7.1. Regional Market Share Analysis, 2025 & 2033
• 7.2. Regional Market Dashboard
• 7.3. Regional Market Snapshot
• 7.4. Remote Patient Monitoring Systems Market Share by Region, 2025 & 2033:
• 7.5. North America
  • 7.5.1. North America remote patient monitoring systems market, 2021 - 2030 (USD Billion)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Scenario
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. Notable Investments
    • 7.5.2.5. U.S. remote patient monitoring systems market, 2021 - 2033 (USD Billion)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Scenario
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. Notable Investments
    • 7.5.3.5. Canada remote patient monitoring systems market, 2021 - 2033 (USD Billion)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Scenario
    • 7.5.4.3. Competitive Scenario
    • 7.5.4.4. Notable Investments
    • 7.5.4.5. Mexico remote patient monitoring systems market, 2021 - 2033 (USD Billion)
• 7.6. Europe
  • 7.6.1. Europe remote patient monitoring systems market, 2021 - 2033 (USD Billion)
  • 7.6.2. UK
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Scenario
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. Notable Investments
    • 7.6.2.5. UK remote patient monitoring systems market, 2021 - 2033 (USD Billion)
  • 7.6.3. Germany
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Scenario
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. Notable Investments
    • 7.6.3.5. Germany remote patient monitoring systems market, 2021 - 2033 (USD Billion)
  • 7.6.4. France
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Scenario
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. Notable Investments
    • 7.6.4.5. France remote patient monitoring systems market, 2021 - 2033 (USD Billion)
  • 7.6.5. Italy
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Scenario
    • 7.6.5.3. Competitive Scenario
    • 7.6.5.4. Notable Investments
    • 7.6.5.5. Italy remote patient monitoring systems market, 2021 - 2033 (USD Billion)
  • 7.6.6. Spain
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Scenario
    • 7.6.6.3. Competitive Scenario
    • 7.6.6.4. Notable Investments
    • 7.6.6.5. Spain remote patient monitoring systems market, 2021 - 2033 (USD Billion)
  • 7.6.7. Norway
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Regulatory Scenario
    • 7.6.7.3. Competitive Scenario
    • 7.6.7.4. Notable Investments
    • 7.6.7.5. Norway remote patient monitoring systems market, 2021 - 2033 (USD Billion)
  • 7.6.8. Sweden
    • 7.6.8.1. Key Country Dynamics
    • 7.6.8.2. Regulatory Scenario
    • 7.6.8.3. Competitive Scenario
    • 7.6.8.4. Notable Investments
    • 7.6.8.5. Sweden remote patient monitoring systems market, 2021 - 2033 (USD Billion)
  • 7.6.9. Denmark
    • 7.6.9.1. Key Country Dynamics
    • 7.6.9.2. Regulatory Scenario
    • 7.6.9.3. Competitive Scenario
    • 7.6.9.4. Notable Investments
    • 7.6.9.5. Denmark remote patient monitoring systems market, 2021 - 2033 (USD Billion)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key Country Dynamics
    • 7.7.1.2. Regulatory Scenario
    • 7.7.1.3. Competitive Scenario
    • 7.7.1.4. Notable Investments
    • 7.7.1.5. Japan remote patient monitoring systems market, 2021 - 2033 (USD Billion)
  • 7.7.2. China
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Scenario
    • 7.7.2.3. Competitive Scenario
    • 7.7.2.4. Notable Investments
    • 7.7.2.5. China remote patient monitoring systems market, 2021 - 2033 (USD Billion)
  • 7.7.3. India
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Scenario
    • 7.7.3.3. Competitive Scenario
    • 7.7.3.4. Notable Investments
    • 7.7.3.5. India remote patient monitoring systems market, 2021 - 2033 (USD Billion)
  • 7.7.4. Australia
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Regulatory Scenario
    • 7.7.4.3. Competitive Scenario
    • 7.7.4.4. Notable Investments
    • 7.7.4.5. Australia remote patient monitoring systems market, 2021 - 2033 (USD Billion)
  • 7.7.5. South Korea
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Regulatory Scenario
    • 7.7.5.3. Competitive Scenario
    • 7.7.5.4. Notable Investments
    • 7.7.5.5. South Korea remote patient monitoring systems market, 2021 - 2033 (USD Billion)
  • 7.7.6. Thailand
    • 7.7.6.1. Key Country Dynamics
    • 7.7.6.2. Regulatory Scenario
    • 7.7.6.3. Competitive Scenario
    • 7.7.6.4. Notable Investments
    • 7.7.6.5. Thailand remote patient monitoring systems market, 2021 - 2033 (USD Billion)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key Country Dynamics
    • 7.8.1.2. Regulatory Scenario
    • 7.8.1.3. Competitive Scenario
    • 7.8.1.4. Notable Investments
    • 7.8.1.5. Brazil remote patient monitoring systems market, 2021 - 2033 (USD Billion)
  • 7.8.2. Argentina
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Scenario
    • 7.8.2.3. Competitive Scenario
    • 7.8.2.4. Notable Investments
    • 7.8.2.5. Argentina remote patient monitoring systems market, 2021 - 2033 (USD Billion)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key Country Dynamics
    • 7.9.1.2. Regulatory Scenario
    • 7.9.1.3. Competitive Scenario
    • 7.9.1.4. Notable Investments
    • 7.9.1.5. South Africa remote patient monitoring systems market, 2021 - 2033 (USD Billion)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key Country Dynamics
    • 7.9.2.2. Regulatory Scenario
    • 7.9.2.3. Competitive Scenario
    • 7.9.2.4. Notable Investments
    • 7.9.2.5. Saudi Arabia remote patient monitoring systems market, 2021 - 2033 (USD Billion)
  • 7.9.3. UAE
    • 7.9.3.1. Key Country Dynamics
    • 7.9.3.2. Regulatory Scenario
    • 7.9.3.3. Competitive Scenario
    • 7.9.3.4. Notable Investments
    • 7.9.3.5. UAE remote patient monitoring systems market, 2021 - 2033 (USD Billion)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key Country Dynamics
    • 7.9.4.2. Regulatory Scenario
    • 7.9.4.3. Competitive Scenario
    • 7.9.4.4. Notable Investments
    • 7.9.4.5. Kuwait remote patient monitoring systems market, 2021 - 2033 (USD Billion)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Company Market Share/ Position Analysis, 2025
• 8.3. Funding Scenario
• 8.4. Company Profiles
  • 8.4.1. Koninklijke Philips N.V.
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Medtronic
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Abbott
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. Masimo
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. GE HealthCare
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. Nihon Kohden Corporation
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Omron Corporation
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Boston Scientific Corporation
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Drager Medical (part of Dragerwerk AG group)
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. Biotronik
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives
  • 8.4.11. Mindray
    • 8.4.11.1. Company overview
    • 8.4.11.2. Financial performance
    • 8.4.11.3. Product benchmarking
    • 8.4.11.4. Strategic initiatives
  • 8.4.12. Welch Allyn (Baxter International)
    • 8.4.12.1. Company overview
    • 8.4.12.2. Financial performance
    • 8.4.12.3. Product benchmarking
    • 8.4.12.4. Strategic initiatives
  • 8.4.13. Smiths Medical (acquired by ICU Medical Inc.)
    • 8.4.13.1. Company overview
    • 8.4.13.2. Financial performance
    • 8.4.13.3. Product benchmarking
    • 8.4.13.4. Strategic initiatives